A fully human monoclonal antibody targeting Semaphorin 5A alleviates the progression of rheumatoid arthritis
Article in Biomedicine & Pharmacotherapy (October 2023)
The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.
Article in Biomedicine & Pharmacotherapy (October 2023)
Article in Frontiers in Immunology (August 2023)
Article in Inflammation (July 2023)